Right when he said,"Tecentriq combined with one of our targeted agents in colorectal cancer," all I could think was it's possibly an Exelixis combo..
Was on CNBC this morning.Did anyone hear what he said?Because I think I heard him being most excited about a combination treatment for Colon Cancer?And since the following is true:Fortunately, it appears Cotellic is working well in colon cancer patients, too. In combination with Roche's Tecentriq, the drugs produced an objective response rate of 17% of the 23 patients in the phase 1b trial, with four confirmed partial responses and five patients with stable disease. Not bad for patients with few options remaining.I wonder if he was thinking about Cotellic?
There is no proof as to what you do.Also learn how to spell and form correct sentences.
Just stating a fact. Your snide remarks on the other hand are uncalled for.So keep them to yourself.It is rather an odd practice to continually post such garbage.
Just stating a fact.You on the other hand never have a worthwhile comment.
Conference Call and Webcast to Follow at 5:00 p.m. EDT/ 2:00 p.m. PDT
Exelixis management will host a conference call to discuss the results and provide a general business update.